Jiang et al.[66] suggested that BCR-ABL transcript levels may be up to 200-fold higher in the most primitive CML progenitors, compared to more differentiated cells. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.